Registration for webinar on nucleic acid therapeutics is open

The registration for our next live webinar is open.

Formulating the Future: Nucleic Acid Therapeutics Explained

On March 5, 2026 our experts Gideon Kersten and Anna Gebhardt will give valuable insights into the exciting landscape of nucleic acid-based therapies, highlighting structures, mechanisms of action, and regulatory approvals, while diving into the challenges and opportunities in drug product development.

Case study will illustrate key stages of the drug product development roadmap and the associated analytical approaches required at each step.